In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.

Suppr

超能文献

作者信息

Resnick L, Markham P D, Veren K, Salahuddin S Z, Gallo R C

出版信息

J Infect Dis. 1986 Dec;154(6):1027-30. doi: 10.1093/infdis/154.6.1027.

DOI:10.1093/infdis/154.6.1027

PMID:3640792

Abstract

摘要

相似文献

In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.

J Infect Dis. 1986 Dec;154(6):1027-30. doi: 10.1093/infdis/154.6.1027.

Suramin in the treatment of AIDS: mechanism of action.

Antiviral Res. 1987 Jan;7(1):1-10. doi: 10.1016/0166-3542(87)90034-9.

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).

Int J Cancer. 1986 Mar 15;37(3):451-7. doi: 10.1002/ijc.2910370318.

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

Lancet. 1985 Sep 21;2(8456):627-30. doi: 10.1016/s0140-6736(85)90002-9.

Implications of the discovery of HTLV-III for the treatment of AIDS.

Cancer Res. 1985 Sep;45(9 Suppl):4685s-4688s.

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

J Clin Pharmacol. 1986 Jan;26(1):22-6. doi: 10.1002/j.1552-4604.1986.tb02897.x.

Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.

Princess Takamatsu Symp. 1984;15:277-88.

Antiviral activity of the polybasic anion, suramin and acyclovir in Hepadna virus infection.

J Antimicrob Chemother. 1986 Oct;18 Suppl B:223-8. doi: 10.1093/jac/18.supplement_b.223.

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

J Interferon Res. 1986 Apr;6(2):143-52. doi: 10.1089/jir.1986.6.143.

New combinations beat HIV in vitro.

Nurs Stand. 1993;7(26):17.

引用本文的文献

Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.

Cell Host Microbe. 2008 Sep 11;4(3):260-270. doi: 10.1016/j.chom.2008.07.008.

Treatment of human immunodeficiency virus infections.

Antimicrob Agents Chemother. 1987 Jun;31(6):839-43. doi: 10.1128/AAC.31.6.839.

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.

Antimicrob Agents Chemother. 1988 Feb;32(2):265-7. doi: 10.1128/AAC.32.2.265.

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Drugs. 1989 Mar;37(3):233-309. doi: 10.2165/00003495-198937030-00002.

Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides.

Antimicrob Agents Chemother. 1990 Oct;34(10):1991-5. doi: 10.1128/AAC.34.10.1991.

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.

Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8806-10. doi: 10.1073/pnas.88.19.8806.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验